Having grasped the knowledge that PD-1 signaling puts the brakes on T-cell activities like activation and cytokine release, and recognizing the significant role of PD-1/PD-L1 in cancer's strategy to suppress T-cell activation, scientists and researchers became deeply intrigued. The gene discussed is CD274; the disease is cancer.